思维纪要社 HTML 来自本地 Obsidian vault 的静态发布
主题 2026-09-17/topics/444.md 原文

#外资研报

图片

无图片

正文

详情页仍未获取到全文。原始列表正文可能被截断。

总体总结

主题正文

  1. 详情页仍未获取到全文。
  2. 原始列表正文可能被截断。

附件总结 GS Consumer - Morning Trading Update -US.pdf

  1. US equities opened lower (SPX futures -65bps, NDX -1.55%, RTY -30bps), pressured by broad-based tech weakness after Anthropic's Amodei called f
  2. slowdown in AI development—an appeal echoed by Altman and Musk—dragging semiconductor-linked names (SMH -4%, SNDK -5%, DELL -3.5%). Cru
  3. (WTI +2.3% to $102.35) following the postponed GCC/Iran meeting in Oman and the continued closure of Saudi Arabia's East-West pipeline after last w
  4. attacks, a dynamic bearing on consumer discretionary input costs and transport-sensitive names. UST yields were largely steady (10yr unchanged at 4.9
  5. -1bp at 5.34%) ahead of the FOMC on Wednesday. Sector focus today centers on the Goldman Sachs Global Consumer & Retail Conference (through 9/
  6. Our two-day GS Retail conferencekicks off today with presentations beginning at 7:45am and 1X1s occurring throughout the session. Full agenda is b
  7. Additionally, Scott’s note this morning also includes 15 stocks / themes that should be topical (link). Overall we head into conference with low positionin
  8. sentiment combined with a challenged macro backdrop (rates, oil, inflation)…but at least the stocks reflect that with the top 10 most requested compa

GS FINS & REITs Daily.pdf

  1. countries for today was indefinitely postponed.....Asia finished mostly lower (Shanghai -7bps/Hang Seng
  2. 200DMA and with a 14dRSI of 48. Financials tracked 9% of S&P constituent volumes with overall single
  3. finished in positive territory. 2yr yield finished +4bps @ 4.63%, 10yr yield flat @ 4.96%, 30yr yield -1bps
  4. the 43rd/39th percentiles vs the past year and in the 20th/23rd percentiles vs the past 5 years. Prime
  5. HIW signed 1,100,000 sqft of second generation leases since July 1st, incl 200,000 sq ft of new leases
  6. higher rates on equities, as the 30-year US Treasury yield has climbed to 5.3% (its highest in nearly 20
  7. most important driver and the index sits within 2% of its record high, with valuations relative to bonds
  8. +9% in the 12 months following a first hike. Higher rates have varying effects across stocks, with home

GS Healthcare- Fluid Dynamics.pdf

  1. Healthcare lagged this back-to-school week(XLV -3.55% vs. SPY -77 bps/SMH +27 bps) amidst a complex interplay of both macro + micro – where (a) an
  2. by a messy set of clinical card flips from NVS (first their Ph3 HORIZON study of Lp(a) missing, then Ph3 HARBOR in DM1 missing) driving a cascade of 2nd/3rd order
  3. drove some strength in other standalone cardiometabolic assets, (iii) and the DM1 failure sparked debates on the appetite to take clinical binary risk via BD, (iv
  4. adding to an on-going vibe shift in preference towards larger, commercial or clinically de-risked SMID biotechs (see ROIV +19% on PH-ILD update this week as among
  5. examples of this) vs. earlier stage assets. This could elevate the focus around near-term pivotal readouts as well, where imminent OPUS-1 data of VAX-31 from PCVX
  6. On non-therapeutics, the fall conference circuit revealing some uneven 3Q trends across subsectors – with (v) Medtech datapoints suggesting pockets of slowness
  7. in the quarter so far, (1) SYK -8.8% Tuesday after commenting on PV business pressures from 2Q continuing into 3Q + potentially 4Q, limited recovery in joint
  8. replacement business vs. expects, (2) BSX -10% on the week, after the company disclosed that it would likely not meet its 3Q and FY26 guide following the recent

GS Healthcare Trading Preview 9-15-26.pdf

  1. medtech. Several headlines overnight/this am (VERA on ORIGIN 3 data, WAY strategic options,
  2. WAY – Bid up 13% on light volume after Reuters reported Waystar is considering strategic
  3. SION - Advancing cystic fibrosis combination to Phase 2. SION announced plans to advance
  4. its dual combination, NBD1 stabilizer SION-451 + SION-2222, into a Phase 2a proof-of-concept
  5. trial in cystic fibrosis in 1Q27 following a post-hoc analysis of the PreciSION CF Phase 2a study
  6. of NBD1 stabilizer SION-719, which recall did not meet its key activity endpoint as an add-on to
  7. biologically active, but its treatment signal was potentially confounded by: (1) pharmacokinetic
  8. Source: Goldman Sachs FICC and Equities as of 9/8/2026. Past Performance is not indicative of Future Results

GS MORNING- 1- Fed Call Change- 2- GCEM ....pdf

  1. 2026/9/14 17:30 * GS MORNING: 1) Fed Call Change, 2) GCEM Macro Symposium, 3) Connecting you to GS, 4) Equities Update and 5) Week Ahead Previews
  2. 2026/9/14 17:30 * GS MORNING: 1) Fed Call Change, 2) GCEM Macro Symposium, 3) Connecting you to GS, 4) Equities Update and 5) Week Ahead Previews
  3. 2026/9/14 17:30 * GS MORNING: 1) Fed Call Change, 2) GCEM Macro Symposium, 3) Connecting you to GS, 4) Equities Update and 5) Week Ahead Previews
  4. 2026/9/14 17:30 * GS MORNING: 1) Fed Call Change, 2) GCEM Macro Symposium, 3) Connecting you to GS, 4) Equities Update and 5) Week Ahead Previews
  5. 2026/9/14 17:30 * GS MORNING: 1) Fed Call Change, 2) GCEM Macro Symposium, 3) Connecting you to GS, 4) Equities Update and 5) Week Ahead Previews
  6. 2026/9/14 17:30 * GS MORNING: 1) Fed Call Change, 2) GCEM Macro Symposium, 3) Connecting you to GS, 4) Equities Update and 5) Week Ahead Previews
  7. 2026/9/14 17:30 * GS MORNING: 1) Fed Call Change, 2) GCEM Macro Symposium, 3) Connecting you to GS, 4) Equities Update and 5) Week Ahead Previews
  8. while food inflation is also likely to tick up slightly. We expect core inflation to remain at 2.6%, with a slight firming

GS-720：中国全球化扩张大潮、中国消费、澳黄金板块、太阳能行业、中国社融、美Com...-20260915.pdf

  1. China’s nearly 40% share of global markets may be unsurprising after a decade of +852-2978-0790 | caleb.chan@gs.com
  2. Goldman Sachs does and seeks to do business with companies covered in its research reports. As a result, investors
  3. should be aware that the firm may have a conflict of interest that could affect the objectivity of this report.
  4. Investors should consider this report as only a single factor in making their investment decision. For Reg AC
  5. www.gs.com/research/hedge.html. Analysts employed by non-US affiliates are not registered/qualified as research
  6. lock-ins offer temporary protection through late 2026, we expect vulnerability to rise in
  7. broader agricultural inflation, given less than 10% cost-of-goods-sold exposure to sugar,
  8. project a narrow 10-8 majority in the dots showing just one hike this year. David Mericle

GS-2026 Communacopia科技大会半导体行业总结-20260912.pdf

  1. bullish on AI infrastructure spending, with Nvidia’s Jensen Huang reiterating $3-$4tn
  2. Goldman Sachs does and seeks to do business with companies covered in its research reports. As a result, investors
  3. should be aware that the firm may have a conflict of interest that could affect the objectivity of this report.
  4. Investors should consider this report as only a single factor in making their investment decision. For Reg AC
  5. www.gs.com/research/hedge.html. Analysts employed by non-US affiliates are not registered/qualified as research
  6. Key Takeaway #7: IT Services - Companies highlighted the increased focus of customers
  7. to broaden. Finally, Credo expects gross margins in FY27 to remain at similar levels to
  8. expected to grow by 48X over the next five years, which is a key driver for its agentic

FW- -GS Sales Note- AI Series- The risk ....pdf

  1. 2026/9/13 17:22 FW: [GS Sales Note]: AI Series: The risk of (Not) investing in China AI (Encore piece, worth the re-reading)
  2. If AI develops as GS economic and industry forecasts project, the potential economic benefits via efficiency gains and new profit creation could be 50% to 100%
  3. Per our Global Economic team's analysis, generative AI is projected to deliver a cumulative boost of 8% to China's labor productivity over the 10 years, equivalent
  4. to $1.6tn of economic value-add in today's dollars, compared to a gross 15% uplift ($4.5tn) for the US. Adhering to their framework and underlying assumptions, we
  5. estimate that the present discounted value (PDV) of the economic benefits from AI (cum efficiency gains and new business opportunity) could reach US$6tn to 7tn in
  6. we note that the total revenue pool globally for Chinese companies could be as high as US$16tn by 2035. Applying a net margin level of around 15% for Chinese AI
  7. tech companies (vs. 10% for the non-AI ones and 25% for US Tech at present) and a cost of equity (COE) of 10%, we calculate that the PDV of the potential AI-
  8. We estimate that widespread AI adoption could improve Chinese corporate earnings by 3pp per annum over the next decade through cost savings/efficiency gain

GS CHINA OPEN.pdf

  1. China A-share cash turnover hit the 2nd lowest level in 2026 on light trading interests ahead of holiday
  2. AI hardware (memory and CPO down over 7%) to Software (Cybersecurity – BUG US EQUITY +10% to
  3. China Auto space today - China’s GAC (601238 CH / 2238 HK) plans to buy FAW stake in an auto JV, The
  4. https://publishing.gs.com/content/research/en/reports/2026/09/14/3515287b-3ca7-45ee-8789-
    • Per the state newspaper – “On the surface, this appears to be a "rational statement" focused on global
  6. 4/ From US overnight: Memory and CPO got sold vs. Cybersecurity – BUG US EQUITY +10% to mark
  7. https://money.usnews.com/investing/news/articles/2026-09-14/chinas-gac-plans-deal-to-buy-faw-
  8. https://money.usnews.com/investing/news/articles/2026-09-14/chinas-pony-ai-unveils-latest-

文档

GS Consumer - Morning Trading Update -US.pdf

总结

  1. US equities opened lower (SPX futures -65bps, NDX -1.55%, RTY -30bps), pressured by broad-based tech weakness after Anthropic's Amodei called f
  2. slowdown in AI development—an appeal echoed by Altman and Musk—dragging semiconductor-linked names (SMH -4%, SNDK -5%, DELL -3.5%). Cru
  3. (WTI +2.3% to $102.35) following the postponed GCC/Iran meeting in Oman and the continued closure of Saudi Arabia's East-West pipeline after last w
  4. attacks, a dynamic bearing on consumer discretionary input costs and transport-sensitive names. UST yields were largely steady (10yr unchanged at 4.9
  5. -1bp at 5.34%) ahead of the FOMC on Wednesday. Sector focus today centers on the Goldman Sachs Global Consumer & Retail Conference (through 9/
  6. Our two-day GS Retail conferencekicks off today with presentations beginning at 7:45am and 1X1s occurring throughout the session. Full agenda is b
  7. Additionally, Scott’s note this morning also includes 15 stocks / themes that should be topical (link). Overall we head into conference with low positionin
  8. sentiment combined with a challenged macro backdrop (rates, oil, inflation)…but at least the stocks reflect that with the top 10 most requested compa

预览

GS Consumer - Morning Trading Update -US.pdf

GS FINS & REITs Daily.pdf

总结

  1. countries for today was indefinitely postponed.....Asia finished mostly lower (Shanghai -7bps/Hang Seng
  2. 200DMA and with a 14dRSI of 48. Financials tracked 9% of S&P constituent volumes with overall single
  3. finished in positive territory. 2yr yield finished +4bps @ 4.63%, 10yr yield flat @ 4.96%, 30yr yield -1bps
  4. the 43rd/39th percentiles vs the past year and in the 20th/23rd percentiles vs the past 5 years. Prime
  5. HIW signed 1,100,000 sqft of second generation leases since July 1st, incl 200,000 sq ft of new leases
  6. higher rates on equities, as the 30-year US Treasury yield has climbed to 5.3% (its highest in nearly 20
  7. most important driver and the index sits within 2% of its record high, with valuations relative to bonds
  8. +9% in the 12 months following a first hike. Higher rates have varying effects across stocks, with home

预览

GS FINS & REITs Daily.pdf

GS Healthcare- Fluid Dynamics.pdf

总结

  1. Healthcare lagged this back-to-school week(XLV -3.55% vs. SPY -77 bps/SMH +27 bps) amidst a complex interplay of both macro + micro – where (a) an
  2. by a messy set of clinical card flips from NVS (first their Ph3 HORIZON study of Lp(a) missing, then Ph3 HARBOR in DM1 missing) driving a cascade of 2nd/3rd order
  3. drove some strength in other standalone cardiometabolic assets, (iii) and the DM1 failure sparked debates on the appetite to take clinical binary risk via BD, (iv
  4. adding to an on-going vibe shift in preference towards larger, commercial or clinically de-risked SMID biotechs (see ROIV +19% on PH-ILD update this week as among
  5. examples of this) vs. earlier stage assets. This could elevate the focus around near-term pivotal readouts as well, where imminent OPUS-1 data of VAX-31 from PCVX
  6. On non-therapeutics, the fall conference circuit revealing some uneven 3Q trends across subsectors – with (v) Medtech datapoints suggesting pockets of slowness
  7. in the quarter so far, (1) SYK -8.8% Tuesday after commenting on PV business pressures from 2Q continuing into 3Q + potentially 4Q, limited recovery in joint
  8. replacement business vs. expects, (2) BSX -10% on the week, after the company disclosed that it would likely not meet its 3Q and FY26 guide following the recent

预览

GS Healthcare- Fluid Dynamics.pdf

GS Healthcare Trading Preview 9-15-26.pdf

总结

  1. medtech. Several headlines overnight/this am (VERA on ORIGIN 3 data, WAY strategic options,
  2. WAY – Bid up 13% on light volume after Reuters reported Waystar is considering strategic
  3. SION - Advancing cystic fibrosis combination to Phase 2. SION announced plans to advance
  4. its dual combination, NBD1 stabilizer SION-451 + SION-2222, into a Phase 2a proof-of-concept
  5. trial in cystic fibrosis in 1Q27 following a post-hoc analysis of the PreciSION CF Phase 2a study
  6. of NBD1 stabilizer SION-719, which recall did not meet its key activity endpoint as an add-on to
  7. biologically active, but its treatment signal was potentially confounded by: (1) pharmacokinetic
  8. Source: Goldman Sachs FICC and Equities as of 9/8/2026. Past Performance is not indicative of Future Results

预览

GS Healthcare Trading Preview 9-15-26.pdf

GS MORNING- 1- Fed Call Change- 2- GCEM ....pdf

总结

  1. 2026/9/14 17:30 * GS MORNING: 1) Fed Call Change, 2) GCEM Macro Symposium, 3) Connecting you to GS, 4) Equities Update and 5) Week Ahead Previews
  2. 2026/9/14 17:30 * GS MORNING: 1) Fed Call Change, 2) GCEM Macro Symposium, 3) Connecting you to GS, 4) Equities Update and 5) Week Ahead Previews
  3. 2026/9/14 17:30 * GS MORNING: 1) Fed Call Change, 2) GCEM Macro Symposium, 3) Connecting you to GS, 4) Equities Update and 5) Week Ahead Previews
  4. 2026/9/14 17:30 * GS MORNING: 1) Fed Call Change, 2) GCEM Macro Symposium, 3) Connecting you to GS, 4) Equities Update and 5) Week Ahead Previews
  5. 2026/9/14 17:30 * GS MORNING: 1) Fed Call Change, 2) GCEM Macro Symposium, 3) Connecting you to GS, 4) Equities Update and 5) Week Ahead Previews
  6. 2026/9/14 17:30 * GS MORNING: 1) Fed Call Change, 2) GCEM Macro Symposium, 3) Connecting you to GS, 4) Equities Update and 5) Week Ahead Previews
  7. 2026/9/14 17:30 * GS MORNING: 1) Fed Call Change, 2) GCEM Macro Symposium, 3) Connecting you to GS, 4) Equities Update and 5) Week Ahead Previews
  8. while food inflation is also likely to tick up slightly. We expect core inflation to remain at 2.6%, with a slight firming

预览

GS MORNING- 1- Fed Call Change- 2- GCEM ....pdf

GS-720：中国全球化扩张大潮、中国消费、澳黄金板块、太阳能行业、中国社融、美Com...-20260915.pdf

总结

  1. China’s nearly 40% share of global markets may be unsurprising after a decade of +852-2978-0790 | caleb.chan@gs.com
  2. Goldman Sachs does and seeks to do business with companies covered in its research reports. As a result, investors
  3. should be aware that the firm may have a conflict of interest that could affect the objectivity of this report.
  4. Investors should consider this report as only a single factor in making their investment decision. For Reg AC
  5. www.gs.com/research/hedge.html. Analysts employed by non-US affiliates are not registered/qualified as research
  6. lock-ins offer temporary protection through late 2026, we expect vulnerability to rise in
  7. broader agricultural inflation, given less than 10% cost-of-goods-sold exposure to sugar,
  8. project a narrow 10-8 majority in the dots showing just one hike this year. David Mericle

预览

GS-720：中国全球化扩张大潮、中国消费、澳黄金板块、太阳能行业、中国社融、美Com...-20260915.pdf

GS-2026 Communacopia科技大会半导体行业总结-20260912.pdf

总结

  1. bullish on AI infrastructure spending, with Nvidia’s Jensen Huang reiterating $3-$4tn
  2. Goldman Sachs does and seeks to do business with companies covered in its research reports. As a result, investors
  3. should be aware that the firm may have a conflict of interest that could affect the objectivity of this report.
  4. Investors should consider this report as only a single factor in making their investment decision. For Reg AC
  5. www.gs.com/research/hedge.html. Analysts employed by non-US affiliates are not registered/qualified as research
  6. Key Takeaway #7: IT Services - Companies highlighted the increased focus of customers
  7. to broaden. Finally, Credo expects gross margins in FY27 to remain at similar levels to
  8. expected to grow by 48X over the next five years, which is a key driver for its agentic

预览

GS-2026 Communacopia科技大会半导体行业总结-20260912.pdf

FW- -GS Sales Note- AI Series- The risk ....pdf

总结

  1. 2026/9/13 17:22 FW: [GS Sales Note]: AI Series: The risk of (Not) investing in China AI (Encore piece, worth the re-reading)
  2. If AI develops as GS economic and industry forecasts project, the potential economic benefits via efficiency gains and new profit creation could be 50% to 100%
  3. Per our Global Economic team's analysis, generative AI is projected to deliver a cumulative boost of 8% to China's labor productivity over the 10 years, equivalent
  4. to $1.6tn of economic value-add in today's dollars, compared to a gross 15% uplift ($4.5tn) for the US. Adhering to their framework and underlying assumptions, we
  5. estimate that the present discounted value (PDV) of the economic benefits from AI (cum efficiency gains and new business opportunity) could reach US$6tn to 7tn in
  6. we note that the total revenue pool globally for Chinese companies could be as high as US$16tn by 2035. Applying a net margin level of around 15% for Chinese AI
  7. tech companies (vs. 10% for the non-AI ones and 25% for US Tech at present) and a cost of equity (COE) of 10%, we calculate that the PDV of the potential AI-
  8. We estimate that widespread AI adoption could improve Chinese corporate earnings by 3pp per annum over the next decade through cost savings/efficiency gain

预览

FW- -GS Sales Note- AI Series- The risk ....pdf

GS CHINA OPEN.pdf

总结

  1. China A-share cash turnover hit the 2nd lowest level in 2026 on light trading interests ahead of holiday
  2. AI hardware (memory and CPO down over 7%) to Software (Cybersecurity – BUG US EQUITY +10% to
  3. China Auto space today - China’s GAC (601238 CH / 2238 HK) plans to buy FAW stake in an auto JV, The
  4. https://publishing.gs.com/content/research/en/reports/2026/09/14/3515287b-3ca7-45ee-8789-
    • Per the state newspaper – “On the surface, this appears to be a "rational statement" focused on global
  6. 4/ From US overnight: Memory and CPO got sold vs. Cybersecurity – BUG US EQUITY +10% to mark
  7. https://money.usnews.com/investing/news/articles/2026-09-14/chinas-gac-plans-deal-to-buy-faw-
  8. https://money.usnews.com/investing/news/articles/2026-09-14/chinas-pony-ai-unveils-latest-

预览

GS CHINA OPEN.pdf

源文件：2026-09-17/topics/444.md
站内副本：2026-09-17/topics/444.md